Sino Biopharmaceutical Announces 2020 First Quarterly Results Sino Biopharmaceutical Limited May 28, 2020 19:59 HKT/SGT Read More
노보텍 (Novotech)과 엔드포인츠 뉴스 (Endpoints News), 아시아 태평양 지역 임상시험 동향을 조망하는 웨비나 (Webinar) 시리즈를 위해 협력 Novotech Health Holdings Pte Ltd May 28, 2020 11:00 HKT/SGT Read More
Novotech and Endpoints to present APAC Clinical Trial webinar series Novotech Health Holdings Pte Ltd May 26, 2020 19:00 HKT/SGT Read More
中国生物制药与康方生物共同开发派安普利新药上市申请获国家药品监督管理局受理 Sino Biopharmaceutical Limited May 26, 2020 17:18 HKT/SGT Read More
中國生物製藥與康方生物共同開發派安普利新藥上市申請獲國家藥品監督管理局受理 Sino Biopharmaceutical Limited May 26, 2020 17:17 HKT/SGT Read More
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration Sino Biopharmaceutical Limited May 26, 2020 17:16 HKT/SGT Read More
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace Fujitsu Ltd May 26, 2020 09:34 HKT/SGT Read More
애질렉스 바이오랩스, 바이오코리아(BIO Korea) 2020에서 임상 시험 비용에 대한 세계 최대 규모 리베이트 등 호주의 강점 선보일 예정 Agilex Biolabs May 21, 2020 09:00 HKT/SGT Read More
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus NanoViricides, Inc. May 20, 2020 19:15 JST Read More
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus NanoViricides, Inc. May 20, 2020 18:15 HKT/SGT Read More
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020 Agilex Biolabs May 20, 2020 17:00 JST Read More
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020 Agilex Biolabs May 20, 2020 16:00 HKT/SGT Read More
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列 Sino Biopharmaceutical Limited May 19, 2020 17:51 HKT/SGT Read More
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列 Sino Biopharmaceutical Limited May 19, 2020 17:50 HKT/SGT Read More
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting Sino Biopharmaceutical Limited May 19, 2020 17:50 HKT/SGT Read More